{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:36:53Z","timestamp":1787315813625,"version":"build-2736575974"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Improved knowledge regarding socio-demographic correlates of people with substance use disorders (SUDs) is essential to better plan and provide adequate services for SUD patients and their families, and to improve our understanding of the complex mechanisms underlying progression into and development of various SUDs. This study aimed to: i) describe demographic, economic, and social correlates of people with SUDs in comparison with those of the general population and ii) compare these correlates across SUDs from licit versus illicit substances, as well as across specific SUDs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A national population-based case\u2013control study included\n                      <jats:italic>all<\/jats:italic>\n                      SUD patients enrolled in specialized drug treatment in Norway in 2009\u20132010 (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u200931\u00a0245) and a population control sample, frequency-matched on age and gender (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u200931\u00a0275). Data on education level, labour market participation, income level and sources, and family\/living arrangement were obtained by linkages to national registers.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Demographic, economic, and social correlates of SUD patients differed substantially from those of the general population, and across specific SUDs. Among SUD patients, those with illicit \u2013 as compared to licit \u2013 SUDs were younger (mean quotient\u2009=\u20090.72 [0.71\u20130.72]), more often had low education level (RR\u2009=\u20091.68 [1.63\u20131.73]), were less often in paid work (RR\u2009=\u20090.74 [0.72\u20130.76]) and had lower income (mean quotient\u2009=\u20090.61 [0.60\u20130.62]). Comparison of patients with different SUD diagnoses revealed substantial demographic differences, including the relatively low mean age among cannabis patients and the high share of females among sedatives\/hypnotics patients. Opioid patients stood out by being older, and more often out of work, receiving social security benefits, and living alone. Cocaine and alcohol patients were more often better educated, included in the work force, and had a better financial situation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Findings revealed substantial and important differences in socio-demographic correlates between SUD patients and the general population, between SUD patients with illicit and with licit substance use, and across specific SUD patient groups.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-022-13199-5","type":"journal-article","created":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T07:04:43Z","timestamp":1650438283000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Patients admitted to treatment for substance use disorder in Norway: a population-based case\u2013control study of socio-demographic correlates and comparative analyses across substance use disorders"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9754-1628","authenticated-orcid":false,"given":"Ellen J.","family":"Amundsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5356-2777","authenticated-orcid":false,"given":"Anne Line","family":"Bretteville-Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8652-9367","authenticated-orcid":false,"given":"Ingeborg","family":"Rossow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,20]]},"reference":[{"issue":"9904","key":"13199_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0140-6736(13)61611-6","volume":"382","author":"HA Whiteford","year":"2013","unstructured":"Whiteford HA, Degenhardt L, Rehm J, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382(9904):575\u20131586. https:\/\/doi.org\/10.1016\/S0140-6736(13)61611-6.","journal-title":"Lancet"},{"key":"13199_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/acprof:oso\/9780199551149.001.0001","volume-title":"Alcohol: No ordinary commodity. Research and public policy","author":"T Babor","year":"2010","unstructured":"Babor T, Caetano R, Casswell S, et al. Alcohol: No ordinary commodity. Research and public policy. 2nd ed. Oxford: Oxford University Press; 2010.","edition":"2"},{"key":"13199_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/oso\/9780198818014.001.0001","volume-title":"Drug Policy and the Public Good","author":"T Babor","year":"2018","unstructured":"Babor T, Caulkin J, Fischer B, et al. Drug Policy and the Public Good. Oxford: Oxford University Press; 2018."},{"issue":"10117","key":"13199_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0140-6736(17)31869-X","volume":"391","author":"RW Aldridge","year":"2018","unstructured":"Aldridge RW, Story A, Hwang SW, et al. Morbidity and mortality in homeless individuals, prisoners, sex workers, and individuals with substance use disorders in high-income countries: a systematic review and meta-analysis. Lancet. 2018;391(10117):241\u201350. https:\/\/doi.org\/10.1016\/S0140-6736(17)31869-X.","journal-title":"Lancet"},{"issue":"2","key":"13199_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11920-019-0997-0","volume":"21","author":"J Rehm","year":"2019","unstructured":"Rehm J, Shield KD. Global burden of disease and the impact of mental and addictive disorders. Curr Psychiat Rep. 2019;21(2):1\u20137. https:\/\/doi.org\/10.1007\/s11920-019-0997-0.","journal-title":"Curr Psychiat Rep"},{"issue":"4","key":"13199_CR6","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1093\/ije\/dyu043","volume":"43","author":"C Probst","year":"2014","unstructured":"Probst C, Roerecke M, Behrendt S, et al. Socioeconomic differences in alcohol-attributable mortality compared with all-cause mortality: a systematic review and meta-analysis. Int J Epidemiol. 2014;43(4):1314\u201327. https:\/\/doi.org\/10.1093\/ije\/dyu043.","journal-title":"Int J Epidemiol"},{"issue":"23","key":"13199_CR7","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1056\/NEJMsa0707519","volume":"358","author":"JP Mackenbach","year":"2008","unstructured":"Mackenbach JP, Stirbu I, Roskam AJR, et al. Socioeconomic inequalities in health in 22 European countries. N Engl J Med. 2008;358(23):2468\u201381. https:\/\/doi.org\/10.1056\/NEJMsa0707519.","journal-title":"N Engl J Med"},{"issue":"8","key":"13199_CR8","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1001\/jamapsychiatry.2015.0584","volume":"72","author":"BF Grant","year":"2015","unstructured":"Grant BF, Goldstein RB, Saha TD, et al. Epidemiology of DSM-5 alcohol use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions III. JAMA Psychiat. 2015;72(8):757\u201366. https:\/\/doi.org\/10.1001\/jamapsychiatry.2015.0584.","journal-title":"JAMA Psychiat"},{"issue":"1","key":"13199_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1001\/jamapsychiatry.2015.2132","volume":"73","author":"BF Grant","year":"2016","unstructured":"Grant BF, Saha TD, Tuan WJ, et al. Epidemiology of DSM-5 drug use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions\u2013III. JAMA Psychiat. 2016;73(1):39\u201347. https:\/\/doi.org\/10.1001\/jamapsychiatry.2015.2132.","journal-title":"JAMA Psychiat"},{"issue":"4","key":"13199_CR10","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.euroneuro.2005.04.005","volume":"15","author":"J Rehm","year":"2005","unstructured":"Rehm J, Room R, van den Brink W, et al. Alcohol use disorders in EU countries and Norway: an overview of the epidemiology. Eur Neuropsychopharm. 2005;15(4):377\u201388. https:\/\/doi.org\/10.1016\/j.euroneuro.2005.04.005.","journal-title":"Eur Neuropsychopharm"},{"issue":"9","key":"13199_CR11","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/10.1016\/S2215-0366(16)30166-3","volume":"3","author":"HG Cheng","year":"2016","unstructured":"Cheng HG, Shidhaye R, Charlson F, et al. Social correlates of mental, neurological, and substance use disorders in China and India: a review. Lancet Psychiatry. 2016;3(9):882\u201399. https:\/\/doi.org\/10.1016\/10.1016\/S2215-0366(16)30166-3.","journal-title":"Lancet Psychiatry"},{"issue":"6","key":"13199_CR12","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1176\/appi.ajp.2015.15070907","volume":"173","author":"D0S Hasin","year":"2016","unstructured":"Hasin D0S, Kerridge BT, Saha TD, et al. Prevalence and correlates of DSM-5 cannabis use disorder, 2012\u20132013: findings from the National Epidemiologic Survey on Alcohol and Related Conditions\u2013III. Am J Psychiat. 2016;173(6):588\u201399. https:\/\/doi.org\/10.1176\/appi.ajp.2015.15070907.","journal-title":"Am J Psychiat"},{"issue":"4","key":"13199_CR13","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.euroneuro.2005.04.004","volume":"15","author":"J Rehm","year":"2005","unstructured":"Rehm J, Room R, van den Brink W, et al. Problematic drug use and drug use disorders in EU countries and Norway: an overview of the epidemiology. Eur Neuropsychopharm. 2005;15(4):389\u201397. https:\/\/doi.org\/10.1016\/j.euroneuro.2005.04.004.","journal-title":"Eur Neuropsychopharm"},{"issue":"1","key":"13199_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/16066350701578136","volume":"16","author":"J Storbj\u00f6rk","year":"2008","unstructured":"Storbj\u00f6rk J, Room R. The two worlds of alcohol problems: Who is in treatment and who is not? Addict Res Theory. 2008;16(1):67\u201384. https:\/\/doi.org\/10.1080\/16066350701578136.","journal-title":"Addict Res Theory"},{"key":"13199_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1744-859X-6-31","volume":"6","author":"I Maremmani","year":"2007","unstructured":"Maremmani I, Pacini M, Pani PP, et al. The mental status of 1090 heroin addicts at entry into treatment: should depression be considered a \u201cdual diagnosis\u201d? Ann Gen Psychiatr. 2007;6:31. https:\/\/doi.org\/10.1186\/1744-859X-6-31.","journal-title":"Ann Gen Psychiatr"},{"issue":"1","key":"13199_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000095810","volume":"13","author":"M Ribeiro","year":"2007","unstructured":"Ribeiro M, Dunn J, Sesso R, et al. Crack cocaine: a five-year follow-up study of treated patients. Eur Addict Res. 2007;13(1):11\u20139. https:\/\/doi.org\/10.1159\/000095810.","journal-title":"Eur Addict Res"},{"issue":"11","key":"13199_CR17","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1111\/add.13889","volume":"112","author":"L Syd\u00e9n","year":"2017","unstructured":"Syd\u00e9n L, Sidoechuk A, Makela P, et al. The contribution of alcohol use and other behavioural, material and social factors to socio-economic differences in alcohol-related disorders in a Swedish cohort. Addiction. 2017;112(11):1920\u201330. https:\/\/doi.org\/10.1111\/add.13889.","journal-title":"Addiction"},{"key":"13199_CR18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12875-015-0308-8","volume":"16","author":"J Rehm","year":"2015","unstructured":"Rehm J, Allemani A, Elekes Z, et al. Alcohol dependence and treatment utilization in Europe \u2013 a representative cross-sectional study in primary care. BMC Fam Pract. 2015;16:90. https:\/\/doi.org\/10.1186\/s12875-015-0308-8.","journal-title":"BMC Fam Pract"},{"issue":"6","key":"13199_CR19","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s00439-012-1168-0","volume":"131","author":"KR Merikangas","year":"2012","unstructured":"Merikangas KR, McClair VL. Epidemiology of substance use disorders. Hum Genet. 2012;131(6):779\u201389. https:\/\/doi.org\/10.1007\/s00439-012-1168-0.","journal-title":"Hum Genet"},{"issue":"1","key":"13199_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/ADM.0000000000000260","volume":"11","author":"AL Bahorik","year":"2017","unstructured":"Bahorik AL, Satre DD, Kline-Simon AH, et al. Alcohol, cannabis, and opioid use disorders, and disease burden in an integrated healthcare system. J Addict Med. 2017;11(1):3\u20139. https:\/\/doi.org\/10.1097\/ADM.0000000000000260.","journal-title":"J Addict Med"},{"issue":"7","key":"13199_CR21","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1093\/aje\/kwj084","volume":"163","author":"M Osler","year":"2006","unstructured":"Osler M, Nordentoft M, Andersen AMN. Childhood social environment and risk of drug and alcohol abuse in a cohort of Danish men born in 1953. Am J Epidemiol. 2006;163(7):654\u201361. https:\/\/doi.org\/10.1093\/aje\/kwj084.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"13199_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0376-8716(00)00155-1","volume":"62","author":"ME McCaul","year":"2001","unstructured":"McCaul ME, Svikis DS, Moore RD. Predictors of outpatient treatment retention: patient versus substance use characteristics. Drug Alcohol Depen. 2001;62(1):9\u201317. https:\/\/doi.org\/10.1016\/S0376-8716(00)00155-1.","journal-title":"Drug Alcohol Depen"},{"key":"13199_CR23","unstructured":"Storbj\u00f6rk J, The social ecology of alcohol and drug treatment: Client experiences in context. 2006, Centrum f\u00f6r socialvetenskaplig alkohol-och drogforskning (SoRAD): Stockholm.Thesis. URN:\u00a0urn:nbn:se:su:diva-1317 ISBN:\u00a091\u20137155\u2013310-X (printed)"},{"issue":"12","key":"13199_CR24","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1111\/j.1360-0443.2011.03563.x","volume":"106","author":"M Lader","year":"2011","unstructured":"Lader M. Benzodiazepines revisited\u2014will we ever learn? Addiction. 2011;106(12):2086\u2013109. https:\/\/doi.org\/10.1111\/j.1360-0443.2011.03563.x.","journal-title":"Addiction"},{"issue":"8","key":"13199_CR25","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMp1715050","volume":"378","author":"A Lembke","year":"2018","unstructured":"Lembke A, Papac J, Humphreys K. Our other prescription drug problem. N Engl J Med. 2018;378(8):693\u20135. https:\/\/doi.org\/10.1056\/NEJMp1715050.","journal-title":"N Engl J Med"},{"key":"13199_CR26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.drugalcdep.2019.02.033","volume":"200","author":"VR Votaw","year":"2019","unstructured":"Votaw VR, Geyer R, Rieselbach MM, et al. The epidemiology of benzodiazepine misuse: a systematic review. Drug Alcohol Depend. 2019;200:95\u2013114. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.02.033.","journal-title":"Drug Alcohol Depend"},{"issue":"12","key":"13199_CR27","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1056\/NEJMra1611832","volume":"376","author":"M Soyka","year":"2017","unstructured":"Soyka M. Treatment of benzodiazepine dependence. N Engl J Med. 2017;376(12):1147\u201357. https:\/\/doi.org\/10.1056\/NEJMra1611832.","journal-title":"N Engl J Med"},{"key":"13199_CR28","volume-title":"Epidemiology: an introduction. 2012","author":"KJ Rothman","year":"2012","unstructured":"Rothman KJ. Epidemiology: an introduction. 2012. Oxford, UK: Oxford University Press; 2012."},{"issue":"1","key":"13199_CR29","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/ije\/19.1.205","volume":"19","author":"L Rodrigues","year":"1990","unstructured":"Rodrigues L, Kirkwood BR. Case-control designs in the study of common diseases: updates on the demise of the rare disease assumption and the choice of sampling scheme for controls. Int J Epidemiol. 1990;19(1):205\u201313. https:\/\/doi.org\/10.1093\/ije\/19.1.205.","journal-title":"Int J Epidemiol"},{"key":"13199_CR30","unstructured":"MedCalc Software Ltd. Relative risk. 2021 [cited 2021 June]; Available from: https:\/\/www.medcalc.org\/calc\/relative_risk.php"},{"key":"13199_CR31","unstructured":"GraphPad. Compute CI of a sum, difference, quotient or product. [cited 2021 June]; Available from: https:\/\/www.graphpad.com\/quickcalcs\/errorProp1\/?Format=SEM"},{"issue":"4","key":"13199_CR32","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1080\/10550887.2012.735563","volume":"31","author":"IN Onyeka","year":"2012","unstructured":"Onyeka IN, Uosukainen H, Korhonen MJ, et al. Sociodemographic characteristics and drug abuse patterns of treatment-seeking illicit drug abusers in Finland, 1997\u20132008: The HUUTI study. J Addict Dis. 2012;31(4):350\u201362. https:\/\/doi.org\/10.1080\/10550887.2012.735563.","journal-title":"J Addict Dis"},{"key":"13199_CR33","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.drugalcdep.2018.11.024","volume":"195","author":"VA Pear","year":"2019","unstructured":"Pear VA, Ponicki WR, Gaidus A, et al. Urban-rural variation in the socioeconomic determinants of opioid overdose. Drug Alcohol Depend. 2019;195:66\u201373. https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.11.024.","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"13199_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11920-018-0940-9","volume":"20","author":"S Suh","year":"2018","unstructured":"Suh S, Cho N, Zhang JH. Sex differences in insomnia: from epidemiology and etiology to intervention. Curr Psychiat Rep. 2018;20(9):1\u201312. https:\/\/doi.org\/10.1007\/s11920-018-0940-9.","journal-title":"Curr Psychiat Rep"},{"issue":"10","key":"13199_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-032888","volume":"9","author":"H Manhica","year":"2019","unstructured":"Manhica H, Lundin A, Danielsson AK. Not in education, employment, or training (NEET) and risk of alcohol use disorder: a nationwide register-linkage study with 485 839 Swedish youths. BMJ Open. 2019;9(10): e032888. https:\/\/doi.org\/10.1136\/bmjopen-2019-032888.","journal-title":"BMJ Open"},{"issue":"1","key":"13199_CR36","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1046\/j.1360-0443.1999.94113310.x","volume":"94","author":"B Claussen","year":"1999","unstructured":"Claussen B. Alcohol disorders and re-employment in a 5-year follow-up of long-term unemployed. Addiction. 1999;94(1):133\u20138. https:\/\/doi.org\/10.1046\/j.1360-0443.1999.94113310.x.","journal-title":"Addiction"},{"key":"13199_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108402","volume":"183","author":"A Verdejo-Garcia","year":"2021","unstructured":"Verdejo-Garcia A, Albein-Urios N. Impulsivity traits and neurocognitive mechanisms conferring vulnerability to substance use disorders. Neuropharmacology. 2021;183: 108402. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108402.","journal-title":"Neuropharmacology"},{"key":"13199_CR38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.paid.2014.01.013","volume":"61","author":"JH Lozano","year":"2014","unstructured":"Lozano JH, Gordillo F, P\u00e9rez MA. Impulsivity, intelligence, and academic performance: testing the interaction hypothesis. Pers Individ Differ. 2014;61:63\u20138. https:\/\/doi.org\/10.1016\/j.paid.2014.01.013.","journal-title":"Pers Individ Differ"},{"key":"13199_CR39","doi-asserted-by":"publisher","unstructured":"Lee RSC, Hoppenbrouwers S, Franken. A systematic meta-review of impulsivity and compulsivity in addictive behaviors. Neuropsychol Rev. 2019;29(1):14\u201326. https:\/\/doi.org\/10.1007\/s11065-019-09402-x","DOI":"10.1007\/s11065-019-09402-x"},{"issue":"4","key":"13199_CR40","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0893-133X(01)00367-0","volume":"26","author":"FA Wagner","year":"2002","unstructured":"Wagner FA, Anthony JC. From first drug use to drug dependence: developmental periods of risk for dependence upon marijuana, cocaine, and alcohol. Neuropsychopharmacol. 2002;26(4):479\u201388. https:\/\/doi.org\/10.1016\/S0893-133X(01)00367-0.","journal-title":"Neuropsychopharmacol"},{"issue":"2\u20133","key":"13199_CR41","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.drugalcdep.2011.08.002","volume":"113","author":"MA Ilgen","year":"2011","unstructured":"Ilgen MA, Price AM, Burnett-Zeigler I, et al. Longitudinal predictors of addictions treatment utilization in treatment-na\u00efve adults with alcohol use disorders. Drug Alcohol Depend. 2011;113(2\u20133):215\u201321. https:\/\/doi.org\/10.1016\/j.drugalcdep.2011.08.002.","journal-title":"Drug Alcohol Depend"},{"key":"13199_CR42","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.drugalcdep.2015.01.031","volume":"149","author":"C Blanco","year":"2015","unstructured":"Blanco C, Iza M, Rodriguez-Fernandez JM, et al. Probability and predictors of treatment-seeking for substance use disorders in the US. Drug Alcohol Depend. 2015;149:136\u201344. https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.01.031.","journal-title":"Drug Alcohol Depend"},{"issue":"10022","key":"13199_CR43","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/S0140-6736(15)00122-1","volume":"387","author":"JP Connor","year":"2016","unstructured":"Connor JP, Haber PS, Hall WD. Alcohol use disorders. The Lancet. 2016;387(10022):988\u201398. https:\/\/doi.org\/10.1016\/S0140-6736(15)00122-1.","journal-title":"The Lancet"},{"issue":"1","key":"13199_CR44","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0306-4603(95)00041-0","volume":"21","author":"R Schober","year":"1996","unstructured":"Schober R, Annis HM. Barriers to help-seeking for change in drinking: a gender-focused review of the literature. Addict Behav. 1996;21(1):81\u201392. https:\/\/doi.org\/10.1016\/0306-4603(95)00041-0.","journal-title":"Addict Behav"},{"issue":"4","key":"13199_CR45","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/acer.13965","volume":"43","author":"PA Gilbert","year":"2019","unstructured":"Gilbert PA, Pro G, Zemore SE, et al. Gender differences in use of alcohol treatment services and reasons for nonuse in a national sample. Alcohol Clin Exp Res. 2019;43(4):722\u201331. https:\/\/doi.org\/10.1111\/acer.13965.","journal-title":"Alcohol Clin Exp Res"},{"issue":"5","key":"13199_CR46","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1017\/S0033291716003032","volume":"47","author":"KS Kendler","year":"2017","unstructured":"Kendler KS, Ohlsson H, Karriker-Jaffe KJ, et al. Social and economic consequences of alcohol use disorder: a longitudinal cohort and co-relative analysis. Psychol Med. 2017;47(5):925\u201335. https:\/\/doi.org\/10.1017\/S0033291716003032.","journal-title":"Psychol Med"},{"key":"13199_CR47","doi-asserted-by":"publisher","first-page":"107990","DOI":"10.1016\/j.drugalcdep.2020.107990","volume":"212","author":"AC Edwards","year":"2020","unstructured":"Edwards AC, Ohlsson H, Sundquist J, et al. Socioeconomic sequelae of drug abuse in a Swedish national cohort. Drug Alcohol Depend. 2020;212:107990. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.107990.","journal-title":"Drug Alcohol Depend"},{"issue":"1\u20132","key":"13199_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1300\/J160v06n01_01","volume":"6","author":"KJ Gruber","year":"2006","unstructured":"Gruber KJ, Taylor MF. A family perspective for substance abuse: Implications from the literature. J Soc Work Pract Addict. 2006;6(1\u20132):1\u201329. https:\/\/doi.org\/10.1300\/J160v06n01_01.","journal-title":"J Soc Work Pract Addict"},{"issue":"3","key":"13199_CR49","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3109\/16066350009004421","volume":"8","author":"GD Walters","year":"2000","unstructured":"Walters GD, Gilbert AA. Defining addiction: contrasting views of clients and experts. Addict Res. 2000;8(3):211\u201320. https:\/\/doi.org\/10.3109\/16066350009004421.","journal-title":"Addict Res"},{"issue":"1","key":"13199_CR50","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1017\/S1092852918001426","volume":"24","author":"T Ramey","year":"2019","unstructured":"Ramey T, Regier PS. Cognitive impairment in substance use disorders. CNS Spectr. 2019;24(1):102\u201313. https:\/\/doi.org\/10.1017\/S1092852918001426.","journal-title":"CNS Spectr"},{"issue":"1\u20132","key":"13199_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2010.01.018","volume":"110","author":"ML Baldwin","year":"2010","unstructured":"Baldwin ML, Marcus SC, De Simone J. Job loss discrimination and former substance use disorders. Drug Alcohol Depend. 2010;110(1\u20132):1\u20137. https:\/\/doi.org\/10.1016\/j.drugalcdep.2010.01.018.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"13199_CR52","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1086\/652386","volume":"39","author":"JP Caulkins","year":"2010","unstructured":"Caulkins JP, Reuter P. How drug enforcement affects drug prices. Crime Justice. 2010;39(1):213\u201371. https:\/\/doi.org\/10.1086\/652386.","journal-title":"Crime Justice"},{"issue":"3","key":"13199_CR53","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1093\/bjc\/azu087","volume":"55","author":"L Moyle","year":"2015","unstructured":"Moyle L, Coomber R. Earning a score: an exploration of the nature and roles of heroin and crack cocaine \u2018user-dealers.\u2019 Brit J Criminol. 2015;55(3):534\u201355. https:\/\/doi.org\/10.1093\/bjc\/azu087.","journal-title":"Brit J Criminol"},{"issue":"1","key":"13199_CR54","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.drugalcdep.2007.05.003","volume":"91","author":"K DeBeck","year":"2007","unstructured":"DeBeck K, Shannon K, Wood E, et al. Income generating activities of people who inject drugs. Drug Alcohol Depend. 2007;91(1):50\u20136. https:\/\/doi.org\/10.1016\/j.drugalcdep.2007.05.003.","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"13199_CR55","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s10654-013-9873-0","volume":"29","author":"LC Thygesen","year":"2014","unstructured":"Thygesen LC, Ersb\u00f8ll AK. When the entire population is the sample: strengths and limitations in register-based epidemiology. Eur J Epidemiol. 2014;29(8):551\u20138. https:\/\/doi.org\/10.1007\/s10654-013-9873-0.","journal-title":"Eur J Epidemiol"},{"key":"13199_CR56","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3389\/fnins.2020.00569","volume":"14","author":"EA Crummy","year":"2020","unstructured":"Crummy EA, O\u2019Neal TJ, Baskin BM, et al. One is not enough: understanding and modeling polysubstance use. Front Neurosci-Switz. 2020;14:569. https:\/\/doi.org\/10.3389\/fnins.2020.00569.","journal-title":"Front Neurosci-Switz"},{"issue":"7","key":"13199_CR57","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.pain.2011.02.045","volume":"152","author":"S Skurtveit","year":"2011","unstructured":"Skurtveit S, Furu K, Borchrevink P, et al. To what extent does a cohort of new users of weak opioids develop persistent or probable problematic opioid use? Pain. 2011;152(7):1555\u201361. https:\/\/doi.org\/10.1016\/j.pain.2011.02.045.","journal-title":"Pain"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-13199-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-022-13199-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-13199-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T09:06:10Z","timestamp":1650531970000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-022-13199-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,20]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["13199"],"URL":"https:\/\/doi.org\/10.1186\/s12889-022-13199-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1026705\/v1","asserted-by":"object"}]},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,20]]},"assertion":[{"value":"28 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Regional Committees for Medical and Health Research Ethics in November 2014 (2014\/438), which also waived the need for informed consent. In addition, approval of the registry linkages was obtained from all registry owners. These approvals included the duty of confidentiality and use of indirectly identifiable health information for research without the data subjects' consent or right of reservation. All experiments were performed in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there are no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"792"}}